贊宇科技調整組織架構 新增運管等三個部門
格隆匯6月12日丨贊宇科技(002637.SZ)宣佈,公司於2020年6月12日召開第五屆董事會第十三次會議,審議通過《關於調整組織架構的議案》。為更好地適應發展規劃及精細化管理的需要,進一步優化資源配置,完善運作機制,進一步提高決策效率和管理水平,為公司持續穩健發展奠定基礎,公司對組織架構做如下調整:辦公室、人力資源部合併為行政人力中心;原市場綜合部、杭油化供應鏈管理部合併為市場綜合中心;戰略發展部更名為投資發展部;新增運營管理部、項目管理辦公室、油酸採銷中心;取消新品拓展部、環保事業部、總工辦。現公司設置有15個部門。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.